Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1993-10-13
|
pubmed:abstractText |
A beta-lactosyl residue was linked to the amino groups of L-lysyl-L-lysine through spacer arms of three different lengths (C2, C4, and C9) to give trivalent beta-lactosyl clusters in order to increase the inhibitory activity of the beta-lactosyl group against tumor cell colonization. Thus, O-(2,3,4,6-tetra-O-acetyl-beta-D-galactopyranosyl)-(1-->4)-2,3, 6-tri-O-acetyl-glucopyranosyl trichloroacetimidate was treated with methyl or benzyl hydroxyethanoate, methyl or benzyl 4-hydroxybutanoate, and methyl 9-hydroxynonanoate, respectively, in the presence of trimethylsilyl trifluoromethanesulfonate to give the corresponding beta-lactosides. These were coupled to L-lysyl-L-lysine, after conversion to the N-hydroxysuccinimide esters, to yield the corresponding trivalent beta-lactosyl-L-lysyl-L-lysine conjugates in good yields. The beta-lactosyl group with a C4 spacer arm was also coupled similarly to poly(L-lysine) (M(r) 3800) to form a polyvalent beta-lactosyl cluster. Coinjection of the trivalent (with C2 and C4 spacer arms) and polyvalent beta-lactosyl clusters with the highly metastatic B16 murine melanoma cells inhibited the formation of lung colonies in C57/BL mice, whereas the trivalent cluster with a C9 spacer arm displayed no activity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticarcinogenic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Dipeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Glycosides,
http://linkedlifedata.com/resource/pubmed/chemical/Indicators and Reagents,
http://linkedlifedata.com/resource/pubmed/chemical/lactosides,
http://linkedlifedata.com/resource/pubmed/chemical/lysyllysine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0008-6215
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
19
|
pubmed:volume |
245
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
175-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8370021-Animals,
pubmed-meshheading:8370021-Anticarcinogenic Agents,
pubmed-meshheading:8370021-Carbohydrate Conformation,
pubmed-meshheading:8370021-Carbohydrate Sequence,
pubmed-meshheading:8370021-Dipeptides,
pubmed-meshheading:8370021-Drug Design,
pubmed-meshheading:8370021-Female,
pubmed-meshheading:8370021-Glycosides,
pubmed-meshheading:8370021-Indicators and Reagents,
pubmed-meshheading:8370021-Lung Neoplasms,
pubmed-meshheading:8370021-Mice,
pubmed-meshheading:8370021-Mice, Inbred C57BL,
pubmed-meshheading:8370021-Molecular Sequence Data,
pubmed-meshheading:8370021-Molecular Structure,
pubmed-meshheading:8370021-Neoplasm Metastasis
|
pubmed:year |
1993
|
pubmed:articleTitle |
Synthesis of multivalent beta-lactosyl clusters as potential tumor metastasis inhibitors.
|
pubmed:affiliation |
Biomembrane Institute and University of Washington, Seattle 98119.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|